Do you want to read an article? Please log in or register.
Clinical and Proteomic Risk Profiles of New-Onset Heart Failure in Men and Women
Heart Failure
Related content
RECOMMENDED
Heart Failure
Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
van Essen BJ, Emmens JE, Tromp J, Ouwerkerk W, Smit MD, Geluk CA, Baumhove L, Suthahar N, Gansevoort RT, Bakker SJL, Damman K, van der Meer P, de Boer RA, van Veldhuisen DJ, Voors AA
doi: 10.1093/eurheartj/ehae868
Heart Failure
Clinical Presentation, Biomarker Trajectories, and Outcomes in Women and Men Hospitalized for Acute Heart Failure
JACC Heart Fail
Ravera A, Qin H, Ter Maaten JM, Santema BT, Adamo M, Ponikowski P, Cotter G, Davison BA, Felker GM, Filippatos GS, Pang PS, Greenberg BH, Gimpelewicz C, Severin T, Teerkink JR, Voors AA, Metra M
doi: 10.1016/j.jchf.2025.102524
Heart Failure
The risk of death according to left ventricular ejection fraction and right ventricular dilatation in 17 321 adults with heart failure from 40 high-, middle- and low-income countries - A Global Congestive Heart Failure (G-CHF) study
Eur J Heart Fail
Leong DP, Joseph PG, Dokainish H, Störk S, McMurray JVV, Mielniczuk LM, Sharma SK, Orlandini A, Karaye KM, Bayes-Genis A, McCready T, Grinvalds A, Balasubramanian K, Branch KR, Kragholm K, Yusuf S, on behalf of the G‐CHF Investigators
doi: 10.1002/ejhf.3550
Heart Failure
Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure: The ARIC Study
JACC Heart Fail
Grant JK, Zhang S, Khan SS, Ozkan B, Blumer V, Nambi V, Echouffo-Tcheugui JB, Pandey A, Blumenthal RS, Ballantyne CM, Selvin E, Matsushita K, Shah A, Coresh J, Ndumele CE
doi: 10.1016/j.jchf.2025.102659
Heart Failure
Ventricular arrhythmias in acute heart failure. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Heart Rhythm Association (EHRA) and the Heart Failure Association (HFA) of the ESC
Eur J Heart Fail
Gorenek B, Wijnmaalen AP, Goette A, Mert GO, Porter B, Gustafsson F, Dan GA, Ector J, Stuehlinger M, Spartalis M, Gosau N, Amir O, Chioncel O
doi: 10.1002/ejhf.3645
Heart Failure
Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial
PLoS One
Bitos K, Laptseva N, Haider T, Rossi VA, Nägele MP, Barthelmes J, Ruschitzka F, Sudano I, Flammer AJ
doi: 10.1371/journal.pone.0325668
Heart Failure
Kidney Tubular Biomarkers Predict Risk of Death and Heart Failure Readmission in Acute Heart Failure
J Am Heart Assoc
Wettersten N, Duff S, Horiuchi Y, van Veldhuisen DJ, Estrella MM, Shlipak MG, Maisel A, Murray PT, Ix JH
doi: 10.1161/JAHA.125.042880
Heart Failure
Finerenone and New York Heart Association Functional Class in Heart Failure: The FINEARTS-HF Trial
JACC Heart Fail
Ostrominski JW, Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Borentian M, Rohwedder K, Lay-Flurrie J, Lavagnino MA, McMurray JJV, Solomon SD
doi: 10.1016/j.jchf.2025.03.007
COMMENTED
Heart Failure
Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Butt JH, Jhund PS, Henderson AD, Claggett BL, Desai AS, Viswanathan P, Kolkhof P, Schloemer P, Amarante F, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Vaduganathan M, Solomon SD, McMurray JJV, FINEARTS-HF Committees and Investigators
doi: 10.1016/S2213-8587(24)00309-7